SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Welcome to the POTP board, the DPP-IV company -- Ignore unavailable to you. Want to Upgrade?

To: rareearth42 who wrote (4)7/22/2006 2:34:41 PM
From: keokalani'nui  Read Replies (2) | Respond to of 90
 
Prevention market presumes you can't tell who may develop VOD, so everyone gets it.

But with the independent study just published in the PR, all VOD was predicted within 24 hours--based on anti-thr3 levels--and Defibrotide + AT3 treatment produced 100% cures.

Still makes money from here, but not nearly as much.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News